Skin Carcinoma — Trials

Skin Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

389 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 127
Recruiting: 69
Ph III recruiting: 8
Growth YoY: +12%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 51–100 of 389 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02721732	Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic	active not recruiting	Phase 2	157	M.D. Anderson Cancer CenterOTHER	1	Jul 17, 2026	clinicaltrials
NCT03906253	Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia	recruiting	N/A	72	Wright State UniversityOTHER	1	Jul 17, 2026	clinicaltrials